Stockscreener 앱 받기
115.43
1.04%
-1.21
시간 외 거래:
115.43
전일 마감가:
$116.64
열려 있는:
$115.51
하루 거래량:
2.34M
Relative Volume:
1.06
시가총액:
$32.62B
수익:
$6.95B
순이익/손실:
$1.30B
주가수익비율:
25.26
EPS:
4.5696
순현금흐름:
$1.15B
1주 성능:
-3.03%
1개월 성능:
-10.52%
6개월 성능:
-7.00%
1년 성능:
-5.31%
1일 변동 폭
$114.45
$117.03
1주일 범위
$113.32
$121.17
52주 변동 폭
$96.43
$160.27
애질런트 테크놀로지스 Stock (A) Company Profile
명칭
Agilent Technologies Inc
전화
(408) 345-8886
주소
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
115.43 | 32.96B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
TMO
Thermo Fisher Scientific Inc
|
500.08 | 189.45B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
195.22 | 140.58B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
598.85 | 48.61B | 4.30B | 1.06B | 1.04B | 13.08 |
|
WAT
Waters Corp
|
299.63 | 29.99B | 3.17B | 642.63M | 516.49M | 10.77 |
애질런트 테크놀로지스 Stock (A) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-20 | 개시 | HSBC Securities | Buy |
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-12-09 | 개시 | Goldman | Buy |
| 2025-12-02 | 개시 | Morgan Stanley | Overweight |
| 2025-10-08 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-10-08 | 업그레이드 | UBS | Neutral → Buy |
| 2025-02-10 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-06-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-04-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-11-17 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-31 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-05-24 | 재확인 | Barclays | Equal Weight |
| 2023-05-24 | 재확인 | BofA Securities | Buy |
| 2023-05-24 | 재확인 | Citigroup | Neutral |
| 2023-05-24 | 재확인 | Credit Suisse | Outperform |
| 2023-05-24 | 재확인 | Evercore ISI | Outperform |
| 2023-05-24 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | 재확인 | Robert W. Baird | Outperform |
| 2023-05-24 | 재확인 | SVB Securities | Outperform |
| 2023-05-24 | 재확인 | Stifel | Hold |
| 2023-05-24 | 재확인 | TD Cowen | Outperform |
| 2023-05-24 | 재확인 | Wells Fargo | Overweight |
| 2023-05-11 | 개시 | Barclays | Equal Weight |
| 2023-01-10 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-07-20 | 개시 | UBS | Buy |
| 2022-07-08 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | 재확인 | BofA Securities | Buy |
| 2022-02-23 | 재확인 | Citigroup | Buy |
| 2022-02-23 | 재확인 | Cowen | Outperform |
| 2022-02-23 | 재확인 | Evercore ISI | Outperform |
| 2022-02-23 | 재확인 | Stifel | Hold |
| 2022-02-23 | 재확인 | Wells Fargo | Overweight |
| 2021-11-23 | 재확인 | BofA Securities | Buy |
| 2021-11-23 | 재확인 | Cowen | Outperform |
| 2021-11-23 | 재확인 | Stifel | Hold |
| 2021-03-18 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-25 | 업그레이드 | UBS | Neutral → Buy |
| 2020-11-17 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | 개시 | Atlantic Equities | Neutral |
| 2020-08-19 | 재확인 | BofA Securities | Neutral |
| 2020-08-19 | 재확인 | Citigroup | Neutral |
| 2020-08-19 | 재확인 | Jefferies | Buy |
| 2020-08-19 | 재확인 | Robert W. Baird | Outperform |
| 2020-08-19 | 재확인 | SVB Leerink | Outperform |
| 2020-08-19 | 재확인 | Stifel | Hold |
| 2020-08-19 | 재확인 | Wells Fargo | Overweight |
| 2020-02-24 | 다운그레이드 | Needham | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-26 | 재확인 | Needham | Buy |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-10-18 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-07-16 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | 다운그레이드 | Barclays | Overweight → Equal Weight |
모두보기
애질런트 테크놀로지스 주식(A)의 최신 뉴스
Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence - GlobeNewswire Inc.
Bank of America Maintains Neutral on Agilent Technologies (A) March 2026 - Meyka
Agilent Technologies: $950 Million Acquisition Of Pathology Diagnostics Company Biocare Medical - Pulse 2.0
Agilent Technologies to acquire Biocare Medical for $950 million - The American Bazaar
Agilent to Acquire Biocare Medical in $950 Million All-Cash Deal - TradingView
Sullivan & Cromwell Advises Agilent On $950M Biocare Buy - Law360
Agilent to buy Biocare Medical for $950M - Healthcare Dive
Agilent Technologies to acquire Biocare Medical in $950m deal - Medical Device Network
BofA reiterates Agilent stock rating on Biocare acquisition - Investing.com
Agilent stock rises on $950M Biocare Medical acquisition - Investing.com South Africa
Agilent expands pathology portfolio with acquisition of Biocare Medical for $950 M - BioSpectrum India
Agilent to acquire Biocare Medical in $950 million all-cash deal - PharmaLive
Sienna Gestion Sells 26,245 Shares of Agilent Technologies, Inc. $A - MarketBeat
Victory Capital Management Inc. Boosts Stake in Agilent Technologies, Inc. $A - MarketBeat
Hims & Hers shares soar premarket; Pfizer, Agilent Technologies slip - Investing.com
Agilent to acquire Biocare Medical for $950M, expanding pathology portfolio - MSN
Agilent Technologies to Acquire Biocare Medical in $950 Million Deal - marketscreener.com
Agilent Bets On Pathology Innovation With Biocare Acquisition - Benzinga
Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions - 01net
M&A News: Agilent to Buy Biocare Medical for $950M — What Investors Should Know - TipRanks
Agilent Technologies, Inc. (NYSE:A) entered into a definitive agreement to acquire Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP for ap - marketscreener.com
Why Agilent Stock Is Slipping Premarket Today - Stocktwits
Excellere Partners and GHO Capital Sell Biocare Medical to Agilent Technologies - National Today
Agilent to buy Biocare Medical in $950 million all-cash deal - marketscreener.com
Agilent Buys Medical Instruments Maker Biocare for $950 Million - Bloomberg
Neo Ivy Capital Management Takes $1.20 Million Position in Agilent Technologies, Inc. $A - MarketBeat
Dimensional Fund Advisors LP Purchases 346,428 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by American Century Companies Inc. - MarketBeat
Agilent Technologies (A) Announces Retirement of Key Executive - GuruFocus
Agilent Technologies: Riding The GLP-1 Therapeutics Wave Across Global Pharmaceutical Laboratories! - Smartkarma
Agilent Technologies announces planned retirement of principal accounting officer - Investing.com
Agilent Announces Planned Retirement of Principal Accounting Officer - TipRanks
Agilent Technologies, Inc. (A) price target cut to $155 at Baird - MSN
Agilent Technologies, Inc. (A) Price Target Cut to $155 at Baird - Finviz
Complementary Methodologies For Analysis Of NISTmAb Impurities - Bioprocess Online
Lab chromatographs are getting smarter: what Agilent is quietly changing for US labs - AD HOC NEWS
Agilent Technologies Signals Steady Growth Amid Headwinds - The Globe and Mail
Agilent (NYSE: A) grows revenue 7% as earnings, cash flow tighten - Stock Titan
[Form 4] AGILENT TECHNOLOGIES, INC. Insider Trading Activity - Stock Titan
Agilent (NYSE: A) CEO surrenders 279 shares to cover RSU tax liability - Stock Titan
Agilent (NYSE: A) SVP surrenders shares to cover tax on RSU vesting - Stock Titan
Agilent Technologies (A) Analyst Rating Update: Morgan Stanley L - GuruFocus
Morgan Stanley Lowers Agilent Technologies (NYSE:A) Price Target to $160.00 - MarketBeat
Morgan Stanley Lowers Price Target on Agilent Technologies to $160 From $180, Keeps Overweight Rating - marketscreener.com
Agilent Technologies Reports Solid Q1 Earnings - National Today
Champlain Investment Partners LLC Has $114.97 Million Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Morgan Stanley cuts Agilent stock price target on valuation multiples By Investing.com - Investing.com UK
Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
Morgan Stanley cuts Agilent stock price target on valuation multiples - Investing.com
Assessing Agilent Technologies (A) Valuation After Recent Share Price Softness and Long Term Gains - Yahoo Finance
Investing in Agilent (A)? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance
애질런트 테크놀로지스 (A) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.98%
자본화:
|
볼륨(24시간):